Show simple item record

dc.contributor.authorWeernink, MGM
dc.contributor.authorvan Til, JA
dc.contributor.authorvan Vugt, JPP
dc.contributor.authorMovig, KLL
dc.contributor.authorGroothuis-Oudshoorn, CGM
dc.contributor.authorIJzerman, MJ
dc.date.accessioned2020-12-17T03:36:14Z
dc.date.available2020-12-17T03:36:14Z
dc.date.issued2016-08-30
dc.identifierpii: PONE-D-16-03432
dc.identifier.citationWeernink, M. G. M., van Til, J. A., van Vugt, J. P. P., Movig, K. L. L., Groothuis-Oudshoorn, C. G. M. & IJzerman, M. J. (2016). Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease. PLOS ONE, 11 (8), https://doi.org/10.1371/journal.pone.0160771.
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/11343/254953
dc.description.abstractINTRODUCTION: Little is known about how patients weigh benefits and harms of available treatments for Parkinson's Disease (oral medication, deep brain stimulation, infusion therapy). In this study we have (1) elicited patient preferences for benefits, side effects and process characteristics of treatments and (2) measured patients' preferred and perceived involvement in decision-making about treatment. METHODS: Preferences were elicited using a best-worst scaling case 2 experiment. Attributes were selected based on 18 patient-interviews: treatment modality, tremor, slowness of movement, posture and balance problems, drowsiness, dizziness, and dyskinesia. Subsequently, a questionnaire was distributed in which patients were asked to indicate the most and least desirable attribute in nine possible treatment scenarios. Conditional logistic analysis and latent class analysis were used to estimate preference weights and identify subgroups. Patients also indicated their preferred and perceived degree of involvement in treatment decision-making (ranging from active to collaborative to passive). RESULTS: Two preference patterns were found in the patient sample (N = 192). One class of patients focused largely on optimising the process of care, while the other class focused more on controlling motor-symptoms. Patients who had experienced advanced treatments, had a shorter disease duration, or were still employed were more likely to belong to the latter class. For both classes, the benefits of treatment were more influential than the described side effects. Furthermore, many patients (45%) preferred to take the lead in treatment decisions, however 10.8% perceived a more passive or collaborative role instead. DISCUSSION: Patients weighted the benefits and side effects of treatment differently, indicating there is no "one-size-fits-all" approach to choosing treatments. Moreover, many patients preferred an active role in decision-making about treatment. Both results stress the need for physicians to know what is important to patients and to share treatment decisions to ensure that patients receive the treatment that aligns with their preferences.
dc.languageEnglish
dc.publisherPUBLIC LIBRARY SCIENCE
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleInvolving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease
dc.typeJournal Article
dc.identifier.doi10.1371/journal.pone.0160771
melbourne.affiliation.departmentMelbourne School of Population and Global Health
melbourne.source.titlePLoS One
melbourne.source.volume11
melbourne.source.issue8
dc.rights.licenseCC BY
melbourne.elementsid1326323
melbourne.contributor.authorIJzerman, Maarten
dc.identifier.eissn1932-6203
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record